✦ LIBER ✦

Secondary T-cell lymphoma in the setting of nodular lymphocyte predominance Hodgkin's disease

✍ Scribed by Dr. A. Tefferi; J. C. Wiltsie; P. J. Kurtin

Publisher: John Wiley and Sons
Year: 1992
Tongue: English
Weight: 210 KB
Volume: 40
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.2830400315

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

LETTER TO THE EDITOR. CD45 IMMUNOSTAININ

LETTER TO THE EDITOR. CD45 IMMUNOSTAINING IN T-CELL-RICH B-CELL LYMPHOMA AND LYMPHOCYTE PREDOMINANCE HODGKIN'S DISEASE

✍ ASHTON-KEY, MARGARET; ISAACSON, PETER G. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB 👁 1 views

AUTHORS' REPLY. HOW TO DIFFERENTIATE BET

AUTHORS' REPLY. HOW TO DIFFERENTIATE BETWEEN T-CELL-RICH B-CELL LYMPHOMA AND LYMPHOCYTE-PREDOMINANT HODGKIN'S DISEASE. EVIDENCE FOR THE VALUE OF MB1 AND 4KB5 IMMUNOSTAINING

✍ SCHMIDT, U.; HERBST, J.; METZ, K. A.; LEDER, L.-D. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB 👁 1 views

We thank Drs Ashton-Key and Isaacson for their interest in our paper. In a similar study on CD45 immunostaining of TCRBCL and LPHD, they found L+H cells positive for either CD45RA (4KB5, 5/12) or CD45RO (UCHL1,7/12). In our series, the L+H cells were found to be 4KB5-as well as UCHL1-negative in 8/1

Soluble fas in the serum of patients wit

Soluble fas in the serum of patients with non-Hodgkin's lymphoma: Higher concentrations in angioimmunoblastic T-cell lymphoma

✍ Yufu, Yuji; Choi, Ilseung; Hirase, Nobuhisa; Tokoro, Akihiro; Noguchi, Yumi; Got 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 25 KB 👁 1 views

The soluble form of Fas (sFas) can block apoptosis induced by the Fas ligand in vitro. A recent report demonstrated that mice injected with sFas displayed autoimmune features. Therefore, an elevated serum concentration of sFas may be associated with lymphoproliferation and autoimmune diseases. We me

The effect of in vitro irradiation on mi

The effect of in vitro irradiation on mitogenic responsiveness of peripheral blood lymphocytes from untreated patients with hodgkin's disease and non-hodgkin's lymphoma

✍ Samuel Rotstein; Edward Baral; Henric Blomgren; Bo Johansson 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 381 KB 👁 2 views

Blood lymphocytes from 20 untreated patients with Hodgkin's disease were compared with those of 20 untreated patients with non-Hodgkin's lymphoma with regard to the responsiveness of the cells to PHA and ConA following exposure to varying doses of ionizing radiation in vitro. Lymphocytes from 19 of

Morphologically normal, CD30-negative B-

Morphologically normal, CD30-negative B-lymphocytes with chromosome aberrations in classical Hodgkin's disease: the progenitor cell of the malignant clone?

✍ Jansen, Maurice P. H. M.; Hopman, Anton H. N.; Bot, Fredrik J.; Haesevoets, Anni 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 235 KB

A recent study observed that numerical chromosome abnormalities in Hodgkin's disease (HD) are detected not only in morphologically abnormal Hodgkin/Reed-Sternberg cells, but also in a fraction of morphologically normal cells. However, the phenotypic constitution of these genetically abnormal, morpho

Expression of high amounts of the CD117

Expression of high amounts of the CD117 molecule in a case of B-cell non-Hodgkin's lymphoma carrying the t(14:18) translocation

✍ Bravo, Pilar; Agust�n, Beatriz D�az; Bellas, Carmen; Gonz�lez, David; C�mara, Ca 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 2 views

The c-kit proto-oncogen (CD117) has been described to be present in normal and neoplastic hemopoietic cells including both myeloid and lymphoid lineages. Among the normal lymphoid cells CD117 expression would be restricted to a small subset of NKcells, and to early T-cell precursors and it is not ex